Resultados de búsqueda - Tamara L. Lotan

Limitar resultados
  1. 1
    Gleason grading of prostatic adenocarcinoma with glomeruloid features on needle biopsy

    Gleason grading of prostatic adenocarcinoma with glomeruloid features on needle biopsy por Tamara L. Lotan, Jonathan I. Epstein

    Publicado 2009
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  2. 2
    Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma

    Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma por Harrison Tsai, Jonathan Lehrer, Mohammed Alshalalfa, Nicholas Erho, Elai Davicioni, Tamara L. Lotan

    Publicado 2017
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage

    Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage por Catherine H. Marshall, Wei Fu, Hao Wang, Alexander S. Baras, Tamara L. Lotan, Emmanuel S. Antonarakis

    Publicado 2018
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    Premalignancy in Prostate Cancer: Rethinking What We Know

    Premalignancy in Prostate Cancer: Rethinking What We Know por Angelo M. De Marzo, Michael C. Haffner, Tamara L. Lotan, Srinivasan Yegnasubramanian, William G. Nelson

    Publicado 2016
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  5. 5
    Clinical and genomic features of <i>SPOP</i>‐mutant prostate cancer

    Clinical and genomic features of <i>SPOP</i>‐mutant prostate cancer por Mari Nakazawa, Mike Fang, Catherine H. Marshall, Tamara L. Lotan, Pedro Isaacsson Velho, Emmanuel S. Antonarakis

    Publicado 2021
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    Estrogen-Dependent and -Independent Estrogen Receptor-α Signaling Separately Regulate Male Fertility

    Estrogen-Dependent and -Independent Estrogen Receptor-α Signaling Separately Regulate Male Fertility por Kerstin W. Sinkevicius, Muriel Lainé, Tamara L. Lotan, Karolina Woloszyn, John H. Richburg, Geoffrey L. Greene

    Publicado 2009
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Immunohistochemical Panel to Identify the Primary Site of Invasive Micropapillary Carcinoma

    Immunohistochemical Panel to Identify the Primary Site of Invasive Micropapillary Carcinoma por Tamara L. Lotan, Huihui Ye, Jonathan Melamed, Xue‐Ru Wu, Ie‐Ming Shih, Jonathan I. Epstein

    Publicado 2009
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma

    ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma por Carlos L. Morais, Liana B. Guedes, Jessica Hicks, Alexander S. Baras, Angelo M. De Marzo, Tamara L. Lotan

    Publicado 2016
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations

    Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations por Emmanuel S. Antonarakis, Farah Shaukat, Pedro Isaacsson Velho, Harsimar Kaur, Eugene Shenderov, Drew M. Pardoll, Tamara L. Lotan

    Publicado 2018
    Enlace del recurso
    Carta
    Agregar a favoritos
    Guardado en:
  10. 10
    Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA‐repair gene mutations in prostate cancer

    Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA‐repair gene mutations in prostate cancer por Pedro Isaacsson Velho, John L. Silberstein, Mark C. Markowski, Jun Luo, Tamara L. Lotan, William B. Isaacs, Emmanuel S. Antonarakis

    Publicado 2018
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  11. 11
    PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort

    PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort por Tamara L. Lotan, Asmus Heumann, Sebastian Dwertmann Rico, Jessica Hicks, Kristen Lecksell, Christina Koop, Guido Sauter, Thorsten Schlomm, Ronald Simon

    Publicado 2017
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  12. 12
    Clinical implications of PTEN loss in prostate cancer

    Clinical implications of PTEN loss in prostate cancer por Tamara Jamaspishvili, David M. Berman, Ashley E. Ross, Howard I. Scher, Angelo M. De Marzo, Jeremy A. Squire, Tamara L. Lotan

    Publicado 2018
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  13. 13
    Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia

    Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia por Tamara L. Lotan, Berrak Gümüşkaya, Hameed A. Rahimi, Jessica Hicks, Tsuyoshi Iwata, Brian D. Robinson, Jonathan I. Epstein, Angelo M. De Marzo

    Publicado 2012
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  14. 14
    Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion

    Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion por Berrak Gümüşkaya, Bora Gürel, Helen Fedor, H-L Tan, Christopher Weier, Jessica Hicks, Michael C. Haffner, Tamara L. Lotan, Angelo M. De Marzo

    Publicado 2013
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  15. 15
    Health inequity drives disease biology to create disparities in prostate cancer outcomes

    Health inequity drives disease biology to create disparities in prostate cancer outcomes por William G. Nelson, Otis W. Brawley, William B. Isaacs, Elizabeth A. Platz, Srinivasan Yegnasubramanian, Karen S. Sfanos, Tamara L. Lotan, Angelo M. De Marzo

    Publicado 2022
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  16. 16
    <scp>GPNMB</scp> expression identifies <scp>TSC1</scp>/2/<scp>mTOR</scp>‐associated and <scp>MiT</scp> family translocation‐driven renal neoplasms

    <scp>GPNMB</scp> expression identifies <scp>TSC1</scp>/2/<scp>mTOR</scp>‐associated and <scp>MiT</scp> family translocation‐driven renal neoplasms por Daniela C. Salles, Kaushal Asrani, Juhyung Woo, Thiago Vidotto, Hans B. Liu, Igor Vidal, Andrés Matoso, George J. Netto, Pedram Argani, Tamara L. Lotan

    Publicado 2022
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  17. 17
    TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations

    TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations por Mark C. Markowski, Cora N. Sternberg, Hao Wang, Tingchang Wang, Laura Linville, Catherine H. Marshall, Rana Sullivan, Serina King, Tamara L. Lotan, Emmanuel S. Antonarakis

    Publicado 2024
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  18. 18
    An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy

    An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy por Emmanuel S. Antonarakis, Daniel Keizman, Zhe Zhang, Bora Gürel, Tamara L. Lotan, Jessica Hicks, Helen Fedor, Michael A. Carducci, Angelo M. De Marzo, Mario A. Eisenberger

    Publicado 2012
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  19. 19
    Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation

    Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation por Jonathan I. Epstein, Mahul B. Amin, Himisha Beltran, Tamara L. Lotan, Juan Miguel Mosquera, Victor E. Reuter, Brian D. Robinson, Patricia Troncoso, Mark A. Rubin

    Publicado 2014
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  20. 20
    Correlation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer

    Correlation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer por Jeffrey J. Tosoian, Michael A. Gorin, Steven P. Rowe, Darian Andreas, Zsolt Szabó, Kenneth J. Pienta, Martin G. Pomper, Tamara L. Lotan, Ashley E. Ross

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: